Thyroid axis function after in-patient treatment of acute psychosis with antipsychotics: a naturalistic study

BMC Psychiatry. 2014 Oct 8:14:279. doi: 10.1186/s12888-014-0279-7.

Abstract

Background: Endocrine function in psychiatric patients may be affected by mental disorder itself as well as by antipsychotic medications.The aim of this naturalistic observational study was to determine if treatment of acute psychotic episode with antipsychotic medication affects thyroid axis hormone concentrations and if such changes are associated with symptomatic improvement.

Methods: Eighty six adult acute psychotic patients, consecutively admitted to a mental hospital, were recruited for the study. All patients were physically healthy and without thyroid disease. During the hospitalization period all study patients received treatment with antipsychotic medication according to clinical need. Severity of the psychotic episode was evaluated using the Brief Psychiatric Rating Scale (BPRS) and venous blood samples were drawn for analysis of free triiodothyronine (FT3), free thyroxine (FT4), and thyroid stimulating hormone (TSH) concentrations on the day of admission and on the day of discharge from the hospital.

Results: Antipsychotic drug treatment was associated with decrease of mean FT3 (p < 0.001) and FT4 (p = 0.002) concentrations; and with increase of mean TSH (p = 0.016) concentrations. Changes in thyroid hormone concentrations were mostly predicted by baseline hormone concentrations. Individual changes were not limited to decrease in high hormone concentrations; in patients who had low FT3 or FT4 concentrations, treatment resulted in increase in concentrations. Such an increase was established in one-quarter of patients for FT3 concentrations and in one-third of patients for FT4 concentrations. Fall in FT4 concentrations negatively correlated with the improvement in the BPRS score (r = -0.235, p = 0.023).

Conclusions: The study indicates that antipsychotic treatment resulted in a decrease in mean FT3 concentrations and in an increase in mean TSH concentrations after recovery from acute psychosis. Symptomatic improvement was less evident in patients who experienced a decrease in FT4 concentrations.

Trial registration: EudraCT No.2007-001541-18.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antipsychotic Agents / pharmacology
  • Antipsychotic Agents / therapeutic use*
  • Female
  • Humans
  • Inpatients
  • Male
  • Middle Aged
  • Psychotic Disorders / blood
  • Psychotic Disorders / drug therapy*
  • Psychotic Disorders / physiopathology
  • Thyroid Function Tests
  • Thyroid Gland / drug effects
  • Thyroid Gland / physiopathology*
  • Thyrotropin / blood
  • Thyroxine / blood
  • Treatment Outcome
  • Triiodothyronine / blood
  • Young Adult

Substances

  • Antipsychotic Agents
  • Triiodothyronine
  • Thyrotropin
  • Thyroxine